Emilio A. Emini

28.4k citations

176 papers · 18.0k indexed · 7 hit papers · h-index 58

Virology top 0.01%
Infectious Diseases top 0.05%
Epidemiology top 0.2%
Molecular Biology top 1%
Immunology top 0.5%

Co-authors: William A. Schleif Paul Deutsch Jon H. Condra Eckard Wimmer Joshua Boger Debra S. Perlow George M. Shaw Beatrice H. Hahn
Topics: HIV Research and Treatment (82 papers)HIV/AIDS drug development and treatment (74 papers)Pneumonia and Respiratory Infections (39 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Germany United Kingdom

In The Last Decade

Emilio A. Emini

175 papers receiving 17.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral dynamics in human immunodeficiency virus type 1 infection

1995 2.6k citations Emilio A. Emini et al. profile →
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 1.5k citations Emilio A. Emini, William A. Schleif et al. profile →
Active human immunodeficiency virus protease is required for viral infectivity.

1988 1.1k citations Emilio A. Emini, William A. Schleif et al. profile →
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

1985 991 citations Emilio A. Emini et al. profile →
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1995 810 citations Jon H. Condra, William A. Schleif et al. profile →
Primary structure, gene organization and polypeptide expression of poliovirus RNA

1981 758 citations Emilio A. Emini et al. profile →
Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant

1990 579 citations John A. Lewis, Emilio A. Emini et al. profile →

Peers

Countries citing papers authored by Emilio A. Emini

Since Specialization

Citations

This map shows the geographic impact of Emilio A. Emini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio A. Emini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio A. Emini more than expected).

Fields of papers citing papers by Emilio A. Emini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio A. Emini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio A. Emini. The network helps show where Emilio A. Emini may publish in the future.

Co-authorship network of co-authors of Emilio A. Emini

This figure shows the co-authorship network connecting the top 25 collaborators of Emilio A. Emini. A scholar is included among the top collaborators of Emilio A. Emini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilio A. Emini. Emilio A. Emini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults 2015 ·Vaccine ·Michael D. Nissen,Helen Marshall,Peter Richmond,Sepehr Shakib,Qin Jiang,David Cooper,(unknown),James Baber,Joseph J. Eiden,William C. Gruber,Kathrin U. Jansen,Emilio A. Emini,Annaliesa S. Anderson,Edward T. Zito,Douglas Girgenti	50
2	Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age 2014 ·Vaccine ·Richard N. Greenberg,Alejandra Gurtman,Robert W. Frenck,Cynthia Strout,Kathrin U. Jansen,James Trammel,Daniel A. Scott,Emilio A. Emini,William C. Gruber,Beate Schmöele-Thoma	115
3	Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico. 2013 ·PubMed ·(unknown),Allison Thompson,Douglas Girgenti,Peter C. Giardina,(unknown),William C. Gruber,Emilio A. Emini,Daniel A. Scott	4
4	Safety of 13-valent pneumococcal conjugate vaccine in infants and children: Meta-analysis of 13 clinical trials in 9 countries 2013 ·Vaccine ·Allison Thompson,Alejandra Gurtman,Scott D. Patterson,Christine Juergens,(unknown),Emilio A. Emini,William C. Gruber,Daniel A. Scott	18
5	Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India 2012 ·The Pediatric Infectious Disease Journal ·(unknown),Sanjay Lalwani,Ashish Bavdekar,Sundaram Balasubramanian,Jugesh Chhatwal,(unknown),Valsan Philip Verghese,S. Tansey,(unknown),Qin Jiang,Michael W. Pride,Emilio A. Emini,William C. Gruber,Daniel A. Scott	16
6	Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Given to Korean Children Receiving Routine Pediatric Vaccines 2012 ·The Pediatric Infectious Disease Journal ·Dong Soo Kim,Seon Hee Shin,Hoan Jong Lee,Young Jin Hong,Soo Young Lee,(unknown),Chi Eun Oh,Ki Hwan Kim,Christine Juergens,Scott D. Patterson,Peter C. Giardina,William C. Gruber,Emilio A. Emini,Daniel A. Scott	18
7	Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine 2011 ·Vaccine ·Janusz Gadzinowski,Piotr Albrecht,(unknown),Ryszard Konior,(unknown),(unknown),(unknown),S. Tansey,Thomas R. Jones,(unknown),Emilio A. Emini,William C. Gruber,Daniel A. Scott	17
8	Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine 2011 ·Vaccine ·Francisco Giménez‐Sánchez,Dorothee Kieninger,(unknown),Federico Martinón‐Torres,(unknown),Javier Díez‐Domingo,(unknown),Christine Juergens,Alejandra Gurtman,Peter C. Giardina,John Z. Liang,William C. Gruber,Emilio A. Emini,Daniel A. Scott	17
9	Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age 2010 ·The Pediatric Infectious Disease Journal ·(unknown),(unknown),Daniëls,Tessa M. John,(unknown),(unknown),(unknown),(unknown),Eva Galiza,S. Tansey,Daniel A. Scott,S. Baker,Taff Jones,(unknown),William C. Gruber,Emilio A. Emini,Saul N. Faust,Adam Finn,Paul T. Heath,Andrew J. Pollard	4
10	[432] FAVORABLE CROSS-RESISTANCE PROFILE OF TWO NOVEL HEPATITIS C VIRUS INHIBITORS, SCH-503034 AND HCV-796, AND ENHANCED ANTI-REPLICON ACTIVITY MEDIATED BY THE COMBINED USE OF BOTH COMPOUNDS 2007 ·Journal of Hepatology ·Anita Y. M. Howe,Robert Ralston,Robert A. Chase,(unknown),Angela Skelton,Mike Flint,(unknown),(unknown),Emilio A. Emini	5
11	Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection 2007 ·Virology ·Zhiqiang Zhang,Danilo R. Casimiro,William A. Schleif,Minchun Chen,Michael Citron,Mary-Ellen Davies,(unknown),Xiaoping Liang,Tong‐Ming Fu,Larry Handt,Emilio A. Emini,John W. Shiver	34
12	Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus 2005 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Lu,(unknown),(unknown),Carrie A. Rutkowski,(unknown),David B. Olsen,William A. Schleif,Anthony Carella,Lori J. Gabryelski,Lixia Jin,Jiunn H. Lin,Emilio A. Emini,Kevin T. Chapman,James R. Tata	8
13	Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay 2004 ·Journal of Immunological Methods ·(unknown),Antonello Pessi,Elisabetta Bianchi,Gennaro Ciliberto,William A. Schleif,(unknown),Renee Danzeisen,Romas Geleziunas,Michael D. Miller,Debra M. Eckert,David Bramhill,Joseph G. Joyce,James C. Cook,(unknown),John W. Shiver,Emilio A. Emini,Mark T. Esser	29
14	Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys 2004 ·Vaccine ·Fan Jiang,Xiaoping Liang,Melanie Horton,Helen C. Perry,Michael Citron,(unknown),Tong‐Ming Fu,Joseph G. Joyce,Craig T. Przysiecki,Paul M. Keller,Victor M. Garsky,Roxana Ionescu,(unknown),Li Shi,Michael Chastain,Jon H. Condra,Mary-Ellen Davies,Jason J. Z. Liao,Emilio A. Emini,John W. Shiver	275
15	Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes 2001 ·Bioorganic & Medicinal Chemistry Letters ·Paul E. Finke,Bryan Oates,Sander G. Mills,Malcolm MacCoss,Lorraine Malkowitz,Martin S. Springer,Sandra L. Gould,Julie A. DeMartino,Anthony Carella,Gwen Carver,Karen Holmes,Renee Danzeisen,Daria J. Hazuda,Joseph Kessler,Janet Lineberger,Michael D. Miller,William A. Schleif,Emilio A. Emini	62
16	Attempted Prophylaxis of Human Immunodeficiency Virus Type 1 Infection in Chimpanzees with a Nonnucleoside Reverse Transcriptase Inhibitor 1994 ·AIDS Research and Human Retroviruses ·William A. Schleif,KRISHNA K. MURTHY,Vinod Sardana,Christine L. Schneider,V W Byrnes,KATHY E. COBB,Elizabeth Röth,Jill Wolfgang,J. M. HOFFMAN,(unknown),(unknown),Emilio A. Emini	4
17	Cyclic V3‐loop‐related HIV‐1 conjugate vaccines Synthesis, conformation and immunological properties 1993 ·International journal of peptide & protein research ·Richard L. Tolman,Maria A. Bednarek,Bruce A. Johnson,W. J. Leanza,Stephen Marburg,Dennis Underwood,Emilio A. Emini,Alan J. Conley	37
18	Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl design 1992 ·Journal of Medicinal Chemistry ·Wayne J. Thompson,Paula M.D. Fitzgerald,M. Katharine Holloway,Emilio A. Emini,(unknown),Brian M. McKeever,William A. Schleif,J C Quintero,(unknown)	137
19	Yeast-Expressed p55 Precursor Core Protein of Human Immunodeficiency Virus Type 1 Does Not Elicit Protective Immunity in Chimpanzees 1990 ·AIDS Research and Human Retroviruses ·Emilio A. Emini,William A. Schleif,J C Quintero,(unknown),Jörg W. Eichberg,George P. Vlasuk,E. Dale Lehman,Mark A. Polokoff,(unknown),Loren D. Schultz,Kathryn J. Hofmann,John A. Lewis,(unknown)	13
20	Effects of Culture Media on Murine Hybridomas: Definition of Optimal Conditions for Hybridoma Viability, Cellular Proliferation, and Antibody Production 1988 ·Hybridoma ·William J. Long,(unknown),Timothy Schofield,Emilio A. Emini	11

About Emilio A. Emini

Emilio A. Emini is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 176 papers that have together received 18.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (82 papers), HIV/AIDS drug development and treatment (74 papers) and Pneumonia and Respiratory Infections (39 papers). The work is most often cited by research in Virology (9.7k citations), Infectious Diseases (9.2k citations) and Immunology (3.0k citations). Emilio A. Emini has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include William A. Schleif, Paul Deutsch, Jon H. Condra, Eckard Wimmer, Joshua Boger, Debra S. Perlow, George M. Shaw, Beatrice H. Hahn, Jeffrey D. Lifson and Victoria A. Johnson. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact